Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schechter

Showing results (181-190 of 189) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 189 results.
Neuropharmacology|July 21, 2009
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonistRobert H Ring, Lee E Schechter, Sarah K Leonard, et al.
Plos Pathogens|October 3, 2014
Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndromeBruno B Andrade, Amrit Singh, Gopalan Narendran, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 14, 2005
Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing propertiesL E Schechter, D L Smith, S Rosenzweig-Lipson, et al.
Journal of Medicinal Chemistry|October 7, 2008
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2Nicole T Hatzenbuhler, Reinhardt Baudy, Deborah A Evrard, et al.
Journal of Medicinal Chemistry|October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonistDerek C Cole, Joseph R Stock, William J Lennox, et al.
Journal of Medicinal Chemistry|September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonistsDahui Zhou, Gary P Stack, Jennifer Lo, et al.
The International Journal of Neuropsychopharmacology|January 6, 2010
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonismJason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2008
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)Warren D Hirst, Terrance H Andree, Suzan Aschmies, et al.
Neuropharmacology|May 4, 2012
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depressionZ A Hughes, S J Neal, D L Smith, et al.
Pageof 19

Showing results (181-190 of 189) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 189 results.
Neuropharmacology|July 21, 2009
Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonistRobert H Ring, Lee E Schechter, Sarah K Leonard, et al.
Plos Pathogens|October 3, 2014
Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndromeBruno B Andrade, Amrit Singh, Gopalan Narendran, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 14, 2005
Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing propertiesL E Schechter, D L Smith, S Rosenzweig-Lipson, et al.
Journal of Medicinal Chemistry|October 7, 2008
Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2Nicole T Hatzenbuhler, Reinhardt Baudy, Deborah A Evrard, et al.
Journal of Medicinal Chemistry|October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonistDerek C Cole, Joseph R Stock, William J Lennox, et al.
Journal of Medicinal Chemistry|September 2, 2009
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonistsDahui Zhou, Gary P Stack, Jennifer Lo, et al.
The International Journal of Neuropsychopharmacology|January 6, 2010
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonismJason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2008
Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405)Warren D Hirst, Terrance H Andree, Suzan Aschmies, et al.
Neuropharmacology|May 4, 2012
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depressionZ A Hughes, S J Neal, D L Smith, et al.
Pageof 19